Hemispherx Biopharma to Present at Noble Financial Capital Markets' Annual Equity Conference
16 mai 2011 12h21 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 16, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that its Senior Advisor to the CEO, Wayne Pambianchi, will...
Hemispherx Biopharma's Ampligen(R) Cited at Barcelona Vaccine & Active Immunotherapeutics Forum 2011
12 mai 2011 13h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 12, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company" or "Hemispherx") today announced that Ampligen® will be featured in a discussion of...
Hemispherx Biopharma Announces Financial Results for the Three Months Ended March 31, 2011
06 mai 2011 16h55 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, May 6, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) announced its financial results for the three months ended March 31, 2011. The net loss for the period was...
Animal Model Data Presented at AACR Indicate That Hemispherx Biopharma's Ampligen(R) May be a Potent Tumor Vaccine Adjuvant
04 avr. 2011 08h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, April 4, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced new data presented yesterday at the American Association for Cancer Research ("AACR") 102nd Annual...
Hemispherx Biopharma, Inc. to Host 2010 Year End Conference Call on Wednesday, April 6, 2011
31 mars 2011 09h56 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 31, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") has scheduled a conference call and audio webcast on Wednesday, April 6, 2011 at 10:00 AM...
Hemisphrex Biopharma Announces Fiscal 2010 Year Results
29 mars 2011 13h21 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 29, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced its financial results for the fiscal year ended December 31, 2010. The net loss for the year (including...
Hemispherx Biopharma Reports on Annual Stockholder Meeting
22 mars 2011 14h26 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 22, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma (NYSE Amex:HEB) announced that it held its 2010 Annual Meeting of Stockholders on March 17, 2011. Final voting results will be...
Hemispherx Biopharma Announces 9th Clinical Investigators Conference: Ampligen Clinical Trials Highlighted
07 mars 2011 14h25 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, March 7, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE:HEB) ("Hemispherx" or the "Company") announced that the Company conducted its 9th Clinical Investigators Conference...
Chronix Biomedical and Hemispherx Biopharma Jointly File Patent Application for a Blood Test for Chronic Fatigue Syndrome (CFS)
03 mars 2011 10h00 HE
|
Hemispherx Biopharma, Inc.
Chronix Technology Focuses on Changes to CFS Patients' DNA
Hemispherx and Chronix Plan Studies to Validate Technology as a Potential Diagnostic Test for CFS
SAN JOSE, Calif., March 3, 2011...
Hemispherx Biopharma Annual Meeting Set
24 févr. 2011 08h00 HE
|
Hemispherx Biopharma, Inc.
PHILADELPHIA, Feb. 24, 2011 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Amex:HEB) (the "Company") will hold its annual meeting of stockholders on Thursday, March 17, 2011, at 10 a.m. EST, in...